|
Gilead Sciences, Inc. (NASDAQ:GILD) Will Beat Forecasts, JPMorgan Says; With …
eMarketsDaily StemCells Inc (NASDAQ:STEM) [Trend Analysis] reported that its aim to propose and sell 11,299,435 shares of common stock and short term warrants for the buy of equal to 9,604,520 additional shares of common stock to two well recognized institutional … |
